Author: Keros Therapeutics, Inc.

Posted Date:

March 9, 2026

Keros Therapeutics Announces Collaboration with Sean M. Healey & AMG Center for ALS

Keros Therapeutics, Inc.

March 9, 2026
Keros Therapeutics Presents Additional Clinical Data from Its Rinvatercept Program at the 2026 MDA Clinical & Scientific Conference

Keros Therapeutics, Inc.

March 9, 2026
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results

Keros Therapeutics, Inc.

March 5, 2026
Keros Therapeutics Appoints Charles Newton to its Board of Directors

Keros Therapeutics, Inc.

February 26, 2026
Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences

Keros Therapeutics, Inc.

February 18, 2026